Literature DB >> 26820739

Right heart chamber geometry and tricuspid annulus morphology in patients undergoing mitral valve repair with and without tricuspid valve annuloplasty.

Gloria Tamborini1, Laura Fusini2, Manuela Muratori2, Paola Gripari2, Sarah Ghulam Ali2, Cesare Fiorentini2, Mauro Pepi2.   

Abstract

According to current recommendations, patients could benefit from tricuspid valve (TV) annuloplasty at the time mitral valve (MV) surgery if tricuspid regurgitation is severe or if tricuspid annulus (TA) dilatation is present. Therefore, an accurate pre-operative echocardiographic study is mandatory for left but also for right cardiac structures. Aims of this study are to assess right atrial (RA), right ventricular (RV) and TA geometry and function in patients undergoing MV repair without or with TV annuloplasty. We studied 103 patients undergoing MV surgery without (G1: 54 cases) or with (G2: 49 cases) concomitant TV annuloplasty and 40 healthy subjects (NL) as controls. RA, RV and TA were evaluated by three-dimensional (3D) transthoracic echocardiography. Comparing the pathological to the NL group, TA parameters and 3D right chamber volumes were significantly larger. RA and RV ejection fraction and TA% reduction were lower in pathological versus NL, and in G2 versus G1. In pathological patients, TA area positively correlated to systolic pulmonary pressure and negatively with RV and RA ejection fraction. Patients undergoing MV surgery and TV annuloplasty had an increased TA dimensions and a more advanced remodeling of right heart chambers probably reflecting an advanced stage of the disease.

Entities:  

Keywords:  Cardiac surgery; Echocardiography; Tricuspid regurgitation; Tricuspid valve repair

Mesh:

Year:  2016        PMID: 26820739     DOI: 10.1007/s10554-016-0846-8

Source DB:  PubMed          Journal:  Int J Cardiovasc Imaging        ISSN: 1569-5794            Impact factor:   2.357


  33 in total

1.  The relation between quantitative right ventricular ejection fraction and indices of tricuspid annular motion and myocardial performance.

Authors:  Darryl Miller; Michel G Farah; Anna Liner; Keith Fox; Mark Schluchter; Brian D Hoit
Journal:  J Am Soc Echocardiogr       Date:  2004-05       Impact factor: 5.251

2.  Pathophysiology of tricuspid regurgitation: quantitative Doppler echocardiographic assessment of respiratory dependence.

Authors:  Yan Topilsky; Christophe Tribouilloy; Hector I Michelena; Sorin Pislaru; Douglas W Mahoney; Maurice Enriquez-Sarano
Journal:  Circulation       Date:  2010-09-27       Impact factor: 29.690

3.  Geometric determinants of functional tricuspid regurgitation: insights from 3-dimensional echocardiography.

Authors:  Thanh-Thao Ton-Nu; Robert A Levine; Mark D Handschumacher; David J Dorer; Chaim Yosefy; Dali Fan; Lanqi Hua; Leng Jiang; Judy Hung
Journal:  Circulation       Date:  2006-07-03       Impact factor: 29.690

Review 4.  Evaluation of the tricuspid valve morphology and function by transthoracic real-time three-dimensional echocardiography.

Authors:  Luigi P Badano; Eustachio Agricola; Leopoldo Perez de Isla; Pasquale Gianfagna; Jose Louis Zamorano
Journal:  Eur J Echocardiogr       Date:  2009-06

5.  Tricuspid regurgitation in patients with severe mitral regurgitation and normal left ventricular ejection fraction: risk factors and prognostic implications in a cohort of 895 patients.

Authors:  Padmini Varadarajan; Ramdas G Pai
Journal:  J Heart Valve Dis       Date:  2010-07

6.  Secondary tricuspid regurgitation or dilatation: which should be the criteria for surgical repair?

Authors:  Gilles D Dreyfus; Pierre J Corbi; K M John Chan; Toufan Bahrami
Journal:  Ann Thorac Surg       Date:  2005-01       Impact factor: 4.330

7.  Prognostic significance of mitral regurgitation and tricuspid regurgitation in patients with left ventricular systolic dysfunction.

Authors:  Todd M Koelling; Keith D Aaronson; Robert J Cody; David S Bach; William F Armstrong
Journal:  Am Heart J       Date:  2002-09       Impact factor: 4.749

8.  Feasibility of a new generation three-dimensional echocardiography for right ventricular volumetric and functional measurements.

Authors:  Gloria Tamborini; Denise Brusoni; Jorge Eduardo Torres Molina; Claudia Agnese Galli; Anna Maltagliati; Manuela Muratori; Francesca Susini; Chiara Colombo; Francesco Maffessanti; Mauro Pepi
Journal:  Am J Cardiol       Date:  2008-05-24       Impact factor: 2.778

9.  Impact of tricuspid regurgitation on survival in patients with chronic heart failure: unexpected findings of a long-term observational study.

Authors:  Stephanie Neuhold; Martin Huelsmann; Elisabeth Pernicka; Alexandra Graf; Diana Bonderman; Christopher Adlbrecht; Thomas Binder; Gerald Maurer; Richard Pacher; Julia Mascherbauer
Journal:  Eur Heart J       Date:  2013-01-18       Impact factor: 29.983

10.  Impact of tricuspid regurgitation on long-term survival.

Authors:  Jayant Nath; Elyse Foster; Paul A Heidenreich
Journal:  J Am Coll Cardiol       Date:  2004-02-04       Impact factor: 24.094

View more
  3 in total

1.  Three-dimensional echocardiography investigation of the mechanisms of tricuspid annular dilatation.

Authors:  Valentina Volpato; Victor Mor-Avi; Federico Veronesi; Karima Addetia; Megan Yamat; Lynn Weinert; Davide Genovese; Gloria Tamborini; Mauro Pepi; Roberto M Lang
Journal:  Int J Cardiovasc Imaging       Date:  2019-08-20       Impact factor: 2.357

2.  Morphometric Study of Mitral Valve Annulus in Iran.

Authors:  Tahereh Mohtaj; Mathias H Aazami; Ghassem Sazegar; Hoorak Poorzand; Aria Hedjazi; Negar Morovatdar; Ahmad Toorabi
Journal:  Galen Med J       Date:  2018-03-31

3.  Myocardial adaptation as assessed by speckle tracking echocardiography after isolated mitral valve surgery for primary mitral regurgitation.

Authors:  Muhammed Gerçek; Lothar Faber; Volker Rudolph; Henrik Fox; Thomas Puehler; Hazem Omran; Lisa Katharina Wolf; Lech Paluszkiewicz; Andreas M Zeiher; Kavous Hakim-Meibodi; Jan Gummert; Zisis Dimitriadis
Journal:  Int J Cardiovasc Imaging       Date:  2020-10-13       Impact factor: 2.357

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.